lobbying_activities: 3440141
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3440141 | 4241abf4-a9aa-4eae-8e7b-65ca36ae5488 | Q3 | HB STRATEGIES | 401104718 | BAYER U.S. LLC | 2025 | third_quarter | PHA | Provide lobbying support on key issues and track relevant federal policy developments that could impact the pharmaceutical, healthcare industries generally and Bayer specifically. | HOUSE OF REPRESENTATIVES,SENATE | 120000 | 0 | 0 | 2025-10-17T11:12:56-04:00 |